Appeals & Response Plans
- Uganda: Cholera Outbreak - Feb 2018
- East Africa: Armyworm Infestation - Mar 2017
- Tanzania: Earthquake - Sept 2016
- South Sudan: Cholera Outbreak - Jul 2016
- Uganda: Yellow Fever Outbreak - Apr 2016
- Uganda: Measles Outbreak - Aug 2013
- Uganda: Cholera Outbreak - May 2013
- Uganda: Floods - May 2013
- Uganda: Marburg Fever Outbreak - Oct 2012
- Uganda: Ebola Outbreak - Jul 2012
Most read (last 30 days)
- Press statement on rumoured Ebola outbreak in Mubende district
- Child Poverty and Deprivation in Refugee-Hosting Areas: Evidence from Uganda
- Uganda / Africa: Refugee Influx from DRC - Emergency Plan of Action (EPoA) update n° 1 DREF n°. MDRUG040
- Uganda: Inter-Agency Operational Update on the DRC Situation #33 (15-21 May 2018)
- OPM-UNHCR Verification Exercise: Update, 18 May 2018
GENEVA - The United Nations Development Programme (UNDP) and the Global Fund have signed a US$10.5 million grant to address human rights barriers faced by vulnerable communities in Africa, and facilitate access to lifesaving health care. The grant is the first of its kind and will cover 10 countries including Botswana, Côte d'Ivoire, Kenya, Malawi, Nigeria, Senegal, the Seychelles, Tanzania, Uganda and Zambia.
KAMPALA, Uganda – Uganda and the Global Fund today signaled a new phase of partnership by signing five new grants for US$226 million to fight HIV and tuberculosis as well as to build resilient and sustainable systems for health in the country.
Funding for grants supported by the Global Fund partnership come from various donors, many of whom were present at a signing ceremony today, including the United States, United Kingdom, European Union, Denmark, Sweden, Belgium, Ireland and South Korea.
Kampala – The U.S. Government, the United Kingdom (U.K.) Government and the Global Fund to Fight AIDS, Tuberculosis and Malaria sealed their commitment to the fight against malaria in Uganda today by finalizing their contribution to the Government of Uganda’s Universal Coverage Campaign. Over 22 million long-lasting insecticide-treated nets (LLINs) for malaria prevention were distributed under the campaign, the largest universal coverage campaign worldwide, which began in the eastern part of the country and extended to the southwest, northern and the central regions.
The Global Fund announced today that 6.6 million people are getting antiretroviral treatment for HIV through programs supported by Global Fund grants, with particularly strong gains in Nigeria, Mozambique, India, and Uganda this year. In mid-year results for 2014, the Global Fund also reported that programs supported by its grants have distributed a total of more than 410 million mosquito nets to protect children and families against malaria, an increase of 14 percent. In addition, 11.9 million people have been treated for tuberculosis in programs supported by the Global Fund.
GENEVA – The Global Fund announced today that 6.6 million people are getting antiretroviral treatment for HIV through programs supported by Global Fund grants, with particularly strong gains in Nigeria, Mozambique, India, and Uganda this year.
In mid-year results for 2014, the Global Fund also reported that programs supported by its grants have distributed a total of more than 410 million mosquito nets to protect children and families against malaria, an increase of 14 percent.
The Global Fund expressed deep concern that Ugandan authorities raided a health clinic and medical research facility, the Makerere University Walter Reed Project, on 3 April leading to the arrest of one of the facility’s employees, and to allegations of “unethical research” and “recruiting homosexuals.” While that individual was later released, the incident significantly heightened concerns about respect for civil society and for the safety of LGBT individuals.
The Global Fund expressed deep concern about a law signed today by President Yoweri Museveni of Uganda that significantly toughens punishments against gay people and carries grave implications for public health.
Studies show that when gay people face discrimination including abuse, incarceration and prosecution, they are less likely to seek HIV testing, prevention and treatment services. Discrimination and stigma curtail access to health services and undermine efforts to control HIV.
New Funding Model Moving Forward
SOROTI, Uganda – The Global Fund to Fight AIDS, Tuberculosis and Malaria announced today that it is supporting Uganda in the distribution of over 15.5 million long lasting insecticide-treated nets, making it the largest malaria prevention campaign this year.
An estimated 300-500 million people are infected with malaria each year worldwide. Most cases occur in sub-Saharan Africa, with approximately 2 million people dying each year.
Overview of the independent evaluation The success of malaria control efforts depends on a high level of coverage in the use of effective antimalarials such as artemisinin-based combination therapies (ACTs). Although these antimalarials have been procured in large amounts by countries, evidence suggests that ACT use still remains far below target levels.
Life-saving malaria treatment can be bought for less than one US dollar Geneva - An innovative initiative led by the Global Fund to Fight AIDS, Tuberculosis and Malaria to put affordable and effective anti-malaria medicines in remote communities in Africa, is making rapid progress in Ghana, Kenya, Madagascar, Nigeria, Tanzania and Uganda.
Joint press release
NAIROBI, KENYA, 27, May 2010 - Government representatives from 20 African countries highly affected by HIV/AIDS gathered today in Nairobi to discuss ways to virtually eliminate mother-to-child transmission of HIV by 2015.
The three-day-consultation from 26 to 28 May is co-organized by the Global Fund to fight AIDS, Tuberculosis and Malaria and UN agencies, including UNAIDS, UNICEF, UNFPA and WHO. Participants are exploring how to expand and strengthen services for pregnant women and increase treatment for infected mothers and children.
Major upscaling of malaria prevention in Ethiopia, Kenya, Tanzania, Uganda and Nigeria
Geneva - The Global Fund to Fight AIDS, Tuberculosis and Malaria announced today that it has transferred USD 336 million to Ethiopia, Kenya, Tanzania, Uganda and Nigeria to pay for the provision of more than 50 million long-lasting insecticidal nets in the next few months. Together, this will amount to a 2/3 increase of the number of bed nets in Africa through Global Fund supported programmes.
Ninety per cent of malaria deaths occur in Africa.
Kampala - The Global Fund to Fight AIDS, Tuberculosis and Malaria said that it is committed to working with the government and other partners in Uganda to accelerate the implementation of Global Fund-supported HIV, tuberculosis and malaria programs.
"We are very pleased to be strengthening our relationship with Uganda, a very important partner of the Global Fund," said Dr William Paton, Director of Country Programs of the Global Fund, who travelled to Kampala to discuss the Global Fund's ongoing engagement and commitment in Uganda.
88 Million Bed Nets Distributed for Malaria
Geneva - The Global Fund to Fight AIDS, Tuberculosis and Malaria today announced that 2.3 million people living with HIV have been reached with lifesaving antiretroviral (ARV) treatment through AIDS programs it supports, a 31 per cent increase over results reported a year ago.
Global Fund-supported tuberculosis programs have so far put more than 5.4 million people on effective TB drugs treatment. Tuberculosis is the leading cause of death among HIV-infected people; the World Health Organization estimates that TB accounts for up to a …
This fact sheet outlines the principles and approach in determining the number of people on antiretroviral drugs (ARVs) for HIV/AIDS treatment, with a breakdown of the results by country, and answers to commonly-asked questions.
Question 1: How many people are receiving ARVs from programs supported by Global Fund grants?
As of June 1st 2009, programs supported by the Global Fund have reported 2.3 million people currently on ARVs for treatment of HIV/AIDS.
Question 2: What is the regional breakdown of people currently receiving ARVs?